Skip to main content

Chronic Rhinitis

0
Pipeline Programs
6
Companies
12
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Neurent Medical
Neurent MedicalIreland - Galway
5 programs
NEUROMARK SystemN/A1 trial
NEUROMARK SystemN/A1 trial
NEUROMARK SystemN/A1 trial
NEUROMARK SystemN/A1 trial
NEUROMARK™ SystemN/A1 trial
Active Trials
NCT05937308Active Not Recruiting150Est. Sep 2027
NCT06128200Completed132Est. Nov 2025
NCT05324397Completed36Est. Oct 2023
+2 more trials
Aerin Medical
Aerin MedicalCA - Mountain View
3 programs
InSecaN/A1 trial
Radiofrequency StylusN/A1 trial
RhinAerN/A3 trials
Active Trials
NCT03727347Completed50Est. Sep 2020
NCT04684875Completed45Est. Jan 2022
NCT06599736Active Not Recruiting25Est. Mar 2026
+2 more trials
Stryker
StrykerCA - San Jose
1 program
ClariFix cryotherapyN/A1 trial
Active Trials
NCT04154605Completed133Est. Jan 2025
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Epidemiological investigationN/A1 trial
Active Trials
NCT06370468Recruiting150,000Est. Aug 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Aerin MedicalRhinAer
UNION therapeuticsEpidemiological investigation
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK™ System
Aerin MedicalRadiofrequency Stylus
Aerin MedicalRhinAer
Aerin MedicalRhinAer
StrykerClariFix cryotherapy
Aerin MedicalInSeca

Clinical Trials (12)

Total enrollment: 151,039 patients across 12 trials

NCT06599736Aerin MedicalRhinAer

A Study of RhinAer Stylus for Treating Chronic Rhinitis

Start: Oct 2024Est. completion: Mar 202625 patients
N/AActive Not Recruiting
NCT06370468UNION therapeuticsEpidemiological investigation

The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis

Start: Apr 2024Est. completion: Aug 2027150,000 patients
N/ARecruiting
NCT06128200Neurent MedicalNEUROMARK System

NEUROMARK Randomized Controlled Trial

Start: Oct 2023Est. completion: Nov 2025132 patients
N/ACompleted
NCT05937308Neurent MedicalNEUROMARK System

NEUROMARK Registry Study

Start: Jun 2023Est. completion: Sep 2027150 patients
N/AActive Not Recruiting
NCT05591989Neurent MedicalNEUROMARK System

Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)

Start: Sep 2022Est. completion: Aug 202580 patients
N/ACompleted
NCT05324397Neurent MedicalNEUROMARK System

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

Start: Mar 2022Est. completion: Oct 202336 patients
N/ACompleted
NCT04769596Neurent MedicalNEUROMARK™ System

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

Start: Feb 2021Est. completion: May 2023143 patients
N/ACompleted
NCT04684875Aerin MedicalRadiofrequency Stylus

Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device

Start: Nov 2020Est. completion: Jan 202245 patients
N/ACompleted
NCT04614324Aerin MedicalRhinAer

A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

Start: Oct 2020Est. completion: Dec 2024129 patients
N/ACompleted
NCT04533438Aerin MedicalRhinAer

RhinAer Procedure for Treatment of Chronic Rhinitis Study

Start: Jul 2020Est. completion: Dec 2024116 patients
N/ACompleted
NCT04154605StrykerClariFix cryotherapy

ClariFix Rhinitis RCT

Start: Nov 2019Est. completion: Jan 2025133 patients
N/ACompleted
NCT03727347Aerin MedicalInSeca

Posterior Nasal Nerve (PNN) Rhinitis Study

Start: Oct 2018Est. completion: Sep 202050 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 151,039 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.